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Abstract
Introduction: Wheat allergy can develop at any stage of life. The aim of this report was to demonstrate that skin testing and specific
IgE have poor specificities and sensitivities for wheat allergy.
Case Presentation: A 37-year-old female presented symptoms that were initiated immediately after consumption of bread and
biscuits. She was well until two months prior to her recent admission. Her skin prick test, RIDA assay, and patch test for wheat
showed negative results despite a history of two episodes of anaphylaxis. She underwent an oral food challenge, which confirmed
wheat allergy. A desensitization procedure was recommended for her. At the end of the immunotherapy process, she had normal
intake of wheat without any symptoms.
Conclusions: Negative sIgE and SPT results do not rule out clinical food allergy. Oral food challenges are still the cornerstone of
diagnosis of food allergy.
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1. Introduction
Food allergy is a general health problem in children
and adults all over the world, affecting 5% of adults and if
IgE-mediated, it is associated with a high risk of fatal ana-
phylaxis (1). Wheat is a widely consumed grain and it is
estimated that almost a half of calories consumed by hu-
mans worldwide come from cereals , particularly wheat
(2). Wheat has a high nutritional value and palatability
(3). Gluten is a mixture of seed storage proteins found
in wheat, which may trigger all kinds of gluten-related
disorders (4). Gluten-related disorders, such as wheat
allergy and celiac disease, are immune-mediated condi-
tions, while non-celiac gluten sensitivity occurs as symp-
tomatic adverse reactions, in which neither allergic nor au-
toimmune mechanisms are involved (5). Wheat allergy is
known as an uncommon cause of food allergy in adults,
particularly when addressing IgE-mediated mechanisms
(6). However, wheat allergy can develop at any stage of life.
Some people can eat bread for years without any ill effects
and then suddenly one day develop symptoms of wheat al-
lergy due to a gradual build-up of wheat antibodies over
time, which, by reaching a critical level, could develop into
respiratory, gastrointestinal and skin reactions.
The aim of this report was to demonstrate that al-
though skin testing and specific IgE are routinely used to
identify sensitization to food, they have poor specificities
and sensitivities for wheat allergy. Therefore, oral food
challenge still acts as the gold standard for identification
of real wheat allergy.
2. Case Presentation
A 37-year-old female was presented to the researchers’
allergy clinic for symptoms that were apparently initiated
immediately after consumption of bread and biscuits. She
had an unremarkable medical history with normal de-
velopmental milestones during childhood. She was oth-
erwise normal without any history of infantile gastroin-
testinal reflux or colitis, atopic dermatitis, allergic rhinitis,
weight loss or chronic diarrhea during childhood, except
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for a state of drowsiness and a sense of itching, which oc-
curred following consumption of bread and biscuits. How-
ever, these objective symptoms were overlooked and she
did not seek medical attention at that time.
She was well until two months prior to her recent
admission at the age of 37 when she experienced itch-
ing, flushing, hypotension, arthralgia, and dizziness af-
ter eating bread and biscuits. Surprisingly, these symp-
toms were more prominent during winter and they were
severe enough to be initiated even by opening of the bis-
cuit box, without eating a piece. There was no similar his-
tory in other family members and her siblings. Her first
anaphylactic episode manifested with generalized body
itching, headache, breathing difficulty, hypotension (70/55
mmHg), and vomiting 20 minutes after eating a biscuit.
She recovered completely from this anaphylactic episode
yet continued to have two more attacks following bread
consumption before presenting to the allergy clinic.
The patient underwent a thorough screening for infec-
tious, hepatic, and metabolic disorders. Table 1 illustrates
the results of some of the assays performed for the patient.
Celiac disease was excluded due to normal serology
(Table 1). Her skin prick test was negative, showing no
sensitivity, particularly to wheat and grass. The RIDA as-
say and patch test for wheat were also negative. Her pul-
monary function test was normal. Nasal smear revealed no
eosinophilia. Furthermore, C1q, anti-C1q, anti-LKM, and im-
mune profile, including serum complement levels, were
all normal.
Because of the existing discrepancy between history
and test results, it was decided to perform an oral food
challenge. The purpose of the challenge was simply to
prove that the patient is allergic to wheat, despite her neg-
ative test results. The challenge was performed after tak-
ing a formal consent in a semi-intensive care unit with
all necessary resuscitation equipment. The patient had
an intravenous access established. Wheat and rice flour
(as placebo) were prepared. The patient did not show any
symptoms while receiving rice flour, yet during the admin-
istration of wheat, she developed erythematous skin rash
(hives), hypotension, and abdominal pain. Therefore, the
challenge was stopped and treatment for anaphylactic re-
action was initiated. A desensitization procedure was rec-
ommended.
Oral immunotherapy was commenced with a starting
dose of 0.01 mg of wheat protein, according to the OIT pro-
tocol shown in Table 2. During six months of desensitiza-
tion, she had two episodes of anaphylaxis with signs and
symptoms, including angioedema, flushing, hypotension,
pruritic erythematous skin, arthralgia, and musculoskele-
tal complaints. At the end of the immunotherapy process,
which lasted six months, she had normal intake of wheat
without any symptoms. Then, a second challenge proce-
Table 1. Results of the Laboratory Tests
Test Result Reference Value
WBC, cell/micL 5.93 P = 56, L = 35, Mo = 7, E = 2
Hg, g/dL 14.3
Platelet 315000
FBS, mg/dL 88 70 - 110
BUN, mg/dL 16 5 - 23
Creatinine, mg/dL 0.8 0.6 - 1.2
Cholesterol, mg/dL 268 150 - 200
Triglyceride, mg/dL 132 30 - 200
AST, IU/L 18 Up to 40
ALT, IU/L 16 Up to 40
T3, ng/dL 105 60 - 220
T4, mcg/dL 7.5 4.5 - 12.5
TSH, micIU/mL 1.4 0.4 - 6.1
Prolactin, micIU/mL 149 30 - 819
Anti Endomysial Ab (IgG) Negative
titer
Up to 1/10
Anti Endomysial Ab (IgA) Negative
titer
Up to 1/10
Anti Gliadin Ab (IgA), U/mL 35 Up to 12




IgA (serum), mg/dL 104.7 71 - 360
HBsAb, mIu/mL 505 ≥ 10
Helicobacter (IgG), Au 31.2 < 20
Helicobacter (IgA), Au 38.9 < 20
dure was performed with all kinds of flour available in the
market to assess tolerance induction. At this point, the
patient tolerated all types of bread without any signs and
symptoms.
3. Discussion
Wheat allergy is more common in children and accord-
ing to the American College of Asthma, Allergy and Im-
munology, about 65% of children outgrow the allergy by
the time they reach adolescence. The prevalence of wheat
allergy is about 0.5%, worldwide (7). While the symptoms
of wheat allergy are usually mild, in some cases it may be-
come severe, although wheat has never been reported as
the cause of fatal anaphylaxis (8). According to a study per-
formed by Scibilia et al. wheat is an important food al-
lergen in adults and should not be overlooked in this age
group (6).
2 Shiraz E-Med J. 2019; 20(2):e83309.
Rekabi M et al.
Table 2. Oral Desensitization Protocol Used for the Patient
Day Dilution 1st Dose/Day Last Dose Final Dose Solution, mg/cc
First Phase: 0.02 g/mL (Semolina)
1 - 18 0.01 mg/cc 1 mL 10 mL 0.3 mg 10/1000
19 - 30 0.1 mg/cc 3 mL 10 mL 3 mg 100/1000
31 - 39 1 mg/cc 3 mL 10 mL 30 mg 1000/1000
40 - 48 2 mg/cc 6 mL 10 mL 60 mg 2000/1000
49 - 57 4 mg/cc 15 mL 10 mL 120 mg 4000/1000
58 - 120 4.5 mg/cc 25 mL 75 mL 1000 mg 4500/1000
Day First Dose Last Dose Final Dose
Second Phase: 1 - 1.4, g (Pasta)
121 - 144 2 pastas 15 pastas twice a day 42 g
145 - 200 15 pastas twice a day 100 pastas a day 70 g
The diagnosis of wheat allergy is based on patient’s
clinical history, detection of wheat-specific IgE, and on the
results of food elimination diets and oral challenges (8).
Once the patient is suspected to suffer from wheat allergy,
the diagnosis should be confirmed by demonstration of
wheat specific-IgE.
The clinical case presented in the current report
showed negative skin prick test and RIDA, despite two
episodes of anaphylactic reactions following ingestion of
wheat. According to the literature, it is believed that wheat
extract IgE testing has a low specificity (2) with a poor
predicting value (1). Again, freshly made solution with
wheat flour, which was prepared and used for skin test did
not contain insoluble major wheat allergens, such as pro-
lamins. In recent studies, component resolved diagnosis
(CRD) has gained interest (1). Considering the role of ma-
jor wheat allergens, which are relevant for inducing food
allergy in Japanese and Swedish studies, Tri a 19, correlated
better with OFC-proven IgE-mediated wheat allergy. How-
ever, this test was not approved by other studies. This test
is not available in Iran. Less difficult blood tests, including
Basophil Activation test are also not available in Iran. Since
oral food challenge is a far more accurate test, it was per-
formed to confirm a true allergic event. Furthermore, the
efficient wheat oral immunotherapy protocol used for this
patient with a history of multiple episodes of anaphylaxis
following consumption of wheat products, demonstrates
real food allergy, despite negative in vitro and in vivo tests.
3.1. Conclusion
This case confirms the difficulty in diagnosis of wheat
allergy. Negative sIgE and SPT results do not rule out clin-
ical food allergy. Also, the size of the skin prick test and
the levels of specific IgE are not useful neither in diagno-
sis of wheat allergy nor in evaluation of wheat tolerance.
Despite the risk of severe allergic reactions with oral food
challenges, they are still the cornerstone of diagnosis of
food allergy and other tests should be considered as addi-
tional tools to aid in the diagnosis of food allergy.
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